Al Ain: Al Jalila Foundation has donated Dh300,000 to Tawam Hospital to cover the treatment costs for patients with cancer and genetic disorders.

The amount was described as a welcome boost by the hospital yesterday (Wednesday) saying that it would give critically ill patients greater access to the best medication, blood tests, X-rays, medical equipment, and chemotherapy.

“The Foundation has aims which are closely aligned with our own — to make lasting and significant contributions in health care to transform lives,” said Gregory F. Schaffer, CEO of Tawam Hospital.

This donation, he said, will no doubt transform the lives of many patients and their families, and will allow clinical teams to advance their practice,” he said. “We are incredibly grateful to Al Jalila Foundation and to His Highness Shaikh Mohammad [Bin Rashid Al Maktoum, UAE Vice-President and Prime Minister and Ruler of Dubai] for their generosity, and will do all we can to provide the best possible treatment and care for those who will benefit from their donation,” said Schaffer.

Dr Abdul Kareem Sultan Al Olama, CEO of Al Jalila Foundation, said debilitating illnesses such as cancer and genetic disorders affect not only the patients themselves but their caregivers and families who often have to put their own lives on hold. “We hope to facilitate medical interventions for hundreds of critically ill patients of all nationalities,” he said.

He said Tawam Hospital is an ideal partner in this endeavour, courtesy of its reputation for world-class standards in oncology and genetic disorders.

Al Jalila Foundation was officially launched as a not-for-profit organisation by Shaikh Mohammad on April 1. The foundation is a local initiative with global aspirations that aims to make lasting and significant contributions in health care to transform lives. The foundation collaborates with other philanthropic organisations, locally and internationally, to achieve regional and global benefits.

Tawam Hospital, in affiliation with Johns Hopkins Medicine and part of the Seha (Abu Dhabi health services) health-care system, is one of the region’s leading centres for oncology and genetic disorder research and treatment.